Mary Harney (Dublin Mid West, Independent)

I do not believe there is any connectivity between the wholesalers and the HSE because the latter's contract is with the retail pharmacists, rather than with the wholesalers. There is connectivity in respect of the retail pharmacists because that is how they are paid. As all data with regard to GMS and drug payment scheme patients are transmitted from the pharmacies to the HSE for payment, they are connected.

As the intention is to start this process on 1 September, the adaptation of the payment system should be possible within that timeframe. Clearly, when legislation of this kind is enacted that results in a change, it is normal practice for discussions to take place. However, I do not envisage that such discussions should delay implementation of the charge. The sector already is aware of the charge, which has been flagged since last year's budget. It was a Government decision related to the budget and consequently there were no surprises. Moreover, the legislation was made available to the Irish Pharmacy Union on its publication last week and clearly, the HSE also has been kept informed of developments regarding the legislation.